Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

February 15, 2007 (Vol. 27, No. 4)

Optimizing Antibody Biomanufacture

Better Processes Can Consistently Yield Both Quality and Quantity

  • The low-hanging fruit is long gone from the bioprocessing tree and even the horse chestnuts in the upper branches are harder to reach. When biotech companies meet in Carlsbad, CA, for the IBC Life Sciences' “Antibody Production and Development” conference in March of this year, they will grapple with ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.